Background-Intermittent positive-pressure ventilation (IPPV) is the "gold standard" of ventilation during cardiopulmonary resuscitation (CPR), but continuous positive airway pressure (CPAP) is increasingly discussed as an alternative. This study investigated hemodynamics and pulmonary gas exchange applying CPAP enhanced with pressure support ventilation (CPAP PSV ) during CPR. Methods and Results-Twenty-four pigs were subjected to ventricular fibrillation and CPR with CPAP PSV , CPAP, or IPPV. Measurements were taken before (hemodynamics, blood gases, inert gas measurements) and 10 (hemodynamics, blood gases) and 20 (hemodynamics, blood gases, inert gas measurements) minutes after induction of ventricular fibrillation. Although no significant intergroup differences in hemodynamics were found, arterial partial pressure of oxygen (PaO 2 ) was significantly higher during CPAP PSV compared with CPAP or IPPV (98Ϯ10, 61Ϯ27, and 71Ϯ30 mm Hg, respectively, PϽ0.05). CPAP PSV resulted in an alveolar-arterial partial pressure of oxygen difference of 56Ϯ17 mm Hg, whereas during CPAP, 83Ϯ21 mm Hg was detected, and during IPPV, 98Ϯ29 mm Hg was detected (PϽ0.05). Pulmonary blood flow to lung units with a normal V A/Q ratio in percent of cardiac output was 76Ϯ17% during CPAP PSV , 61Ϯ21% during CPAP (PϽ0.01), and 54Ϯ13% during IPPV (PϽ0.01). Oxygen uptake (V O 2 ) was significantly higher during CPAP PSV than with the other ventilation modes (PϽ0.05) and comparable to the baseline value in intragroup comparison. Return of spontaneous circulation was recorded in 8 of 8 animals in the CPAP PSV group, in 6 of 8 in the CPAP group, and in 3 of 8 in the IPPV group.
R estoration of spontaneous circulation (ROSC) is the main goal of cardiopulmonary resuscitation (CPR), and establishing adequate ventilation may be a second-line measure, 1 because ventilation alone is worthless without spontaneous cardiac function having been restored. 2 In addition, ventilatory requirements during cardiac arrest are low. Accordingly, chest compressions alone without patent airway suffice during the early phases of CPR. 3 The American Heart Association recommends intermittent positive-pressure ventilation (IPPV) as the respiratory mode during advanced cardiac life support. 4 Once an endotracheal tube is positioned in the trachea, ventilation does not need to be synchronized with chest compressions. The extent of interference between chest compressions and ventilatory cycles is largely unknown. For this reason and for reasons of easier operability, other approaches than IPPV are sought. [5] [6] [7] A promising alternative was examined by Hevesi et al, 7 who showed that continuous positive airway pressure (CPAP) is comparable or even superior to IPPV. On the basis of elastic recoil of thorax and lung, they clearly showed that during CPR and CPAP, expiration resulted from active thoracic compression, whereas inspiration was passive. 7 In contrast to IPPV in this setting, CPAP delivers the inspiratory tidal volume (VT) strictly during decompression.
Pressure support ventilation (PSV) normally is used to deliver patient-triggered inspiratory help. 8 An inspiratory effort of the patient is aided by a preset amount of inspiratory pressure support. During CPR, thoracic decompression must be followed by airflow to the subject, which is likely to be detected by the ventilator's flow sensor. We therefore hypothesized that the decompression-induced airflow would trigger the ventilator. We also hypothesized that PSV, which resembles a triggered ventilation with inspiration during decompression, would result in a higher amount of blood flow to lung units with a normal V A/Q ratio compared with IPPV or CPAP and a subsequently higher arterial partial pressure of oxygen (PaO 2 ) during CPR.
Methods
The Austrian Federal Animal Investigational Committee approved this project, and animals were managed in accordance with the National Institutes of Health guidelines. This study was performed on 24 healthy, 16-week-old white farm pigs weighing 37 to 40 kg. Pigs were premedicated with azaperone (4 mg/kg IM) and atropine (0.01 mg/kg IM), and anesthesia was induced with propofol (2 to 4 mg/kg IV). After the trachea had been intubated, lungs were ventilated in IPPV mode (Evita 4, Dräger) at an inspiratory fraction of O 2 of 0.3 and a VT of 10 mL/kg at 18 breaths/min. Respiratory rate was then adjusted to achieve a PaCO 2 between 35 and 40 mm Hg. Anesthesia was maintained with propofol (6 to 8 mg · kg Ϫ1 · h Ϫ1 ) and piritramide boluses (30 to 45 mg each). Ringer's lactate solution (6 mL · kg Ϫ1 · h Ϫ1 ) and 3% gelatin solution (4 mL · kg Ϫ1 · h Ϫ1 ) were administered during the preparation phase and postresuscitation phase. A standard lead II ECG was used to monitor cardiac rhythm. Body temperature was maintained between 38°C and 39°C. Anesthesia was stopped during CPR.
Hemodynamic Measurements
A 7F catheter was advanced into a femoral artery for withdrawal of arterial blood and measurement of arterial blood pressure. A 7F pulmonary artery catheter was advanced into the pulmonary artery to measure mean pulmonary artery pressure, pulmonary arterial occlusion pressure, and cardiac output (CO) by the thermodilution technique (10 mL iced saline in triplicate) and to withdraw mixed venous blood. All catheters were filled with saline and connected to pressure transducers zeroed to ambient pressure at the level of the right atrium.
Blood Gas, Inert Gas, and Expiratory Measurements
Arterial and mixed venous blood gas variables were measured with a blood gas analyzer (Chiron), and end-tidal carbon dioxide was measured with a CO 2 analyzer (Dräger). Distributions of ventilation and perfusion were determined with the MIGET, as previously described. 9 (5) ventilation of unperfused lung units, alveolar dead space (V A/Q Ͼ100 through infinity). The residual sum of squares was used as an indicator of fit of the data to the 50-compartment model. 12 
Experimental Procedure
Fifteen minutes before cardiac arrest, 5000 U heparin IV (clotting prevention) and 0.4 mg/kg piritramide were given. A 50-Hz, 60-V AC was then applied via 2 subcutaneous needle electrodes to induce ventricular fibrillation. CPR was started immediately. Animals randomly assigned to receive either IPPV, CPAP, or CPAP with PSV (CPAP PSV ) were continued on the respective mode. CPAP and the pressure support in CPAP PSV were set to 12 cm H 2 O. Baseline measurements (hemodynamics, inert gases, blood gases) were taken before ventricular fibrillation was induced. Repeated measurements were taken 10 minutes (hemodynamics, blood gases) and 20 minutes (hemodynamics, inert gases, blood gases) after induction of ventricular fibrillation. Closed-chest CPR was performed at a rate of 80 compressions/min with a mechanical device (Thumper, model 1016, Michigan Instruments Inc). Precordial compression force was adjusted to produce a sternal depression of 4 cm with a compressionrelaxation ratio of 1:1. 7 The end point of the experiment was defined as hemodynamics and pulmonary gas exchange after 20 minutes of CPR without pharmacological intervention. However, we attempted to resuscitate the animals with vasopressin (0.4 U/kg) and up to 5 monophasic countershocks with an energy of 3, 4, and 6 J/kg, respectively. If asystole or pulseless electrical activity persisted after the 6-J/kg countershocks had been given, the resuscitation effort was terminated. ROSC was defined as an unassisted pulse with a systolic arterial pressure of Ն80 mm Hg, lasting for Ն5 minutes. Anesthesia was continued after ROSC and ventilation continued in IPPV mode.
Statistical Analysis
A 2-way ANOVA for repeated measures was used to determine statistical intergroup and intragroup significance. Significant results were analyzed post hoc with the Newman-Keuls and Fisher's exact tests. Data are presented as meanϮSD in the text, whereas error bars in the figures reflect SEM for reasons of space and clarity; a 2-tailed value of PϽ0.05 was considered significant.
Results
Before induction of cardiac arrest, there was no significant intergroup difference in any measured variable. Results described below refer to the time point after 20 minutes of CPR. 
Inert Gas Measurements
Inert gas data are presented in Table 1 . CPAP PSV resulted in the highest blood flow to lung units with a normal V A/Q ratio during CPR, whereas in animals treated with CPAP, the highest blood flow was to lung units with a low V A/Q ratio, and in animals treated with IPPV, the highest blood flow to lung units with a high V A/Q ratio was recorded. Differences in inert gas shunt were not significant. In animals treated with IPPV, higher values of the mean of the distributions of ventilation and perfusion were noted. SDs of either the distribution of ventilation (log SDV) or perfusion (log SDQ) did not undergo significant changes, indicating that the width of the distributions did not change. Alveolar dead space ventilation after 20 minutes of CPR was significantly lower in animals treated with IPPV (50Ϯ27%) than with CPAP (88Ϯ6%) or with CPAP PSV (75Ϯ17%). The adequacy of the multiple inert gas technique requires a steady-state condition. This can be evaluated by comparing thermodilutionmeasured cardiac output with the prediction of the inert gas algorithm, the latter being based on the Fick principle. Values were essentially identical.
Blood Gas Variables and End-Tidal Carbon Dioxide
Blood gas variables are shown in Figures 1 and 2 and in Table  2 . Intergroup differences were observed in all oxygen-related variables. PaO 2 was significantly higher in animals treated with CPAP PSV than in animals treated with CPAP (PϽ0.01) or IPPV (PϽ0.05). Mixed venous oxyhemoglobin saturation was significantly higher in animals ventilated with CPAP or IPPV than in the CPAP PSV animals, whereas CPAP animals had lower (PϽ0.01) arterial oxyhemoglobin saturations after 20 minutes of CPR. No significant intergroup difference was found in other blood gas variables. End-tidal carbon dioxide was higher in animals of the CPAP PSV group than in animals treated with CPAP or IPPV.
Alveolar-arterial oxygen pressure difference (AaDO 2 ) and oxygen uptake (V O 2 ) at the measurement after 20 minutes of CPR are given in Figures 1 (top) and 2 (top) . In an intergroup comparison with CPAP PSV , AaDO 2 was higher in animals treated with CPAP or IPPV. V O 2 was not significantly lower during CPR when CPAP PSV was applied (Pϭ0.23) compared with the baseline value. This variable was significantly higher, however, in intergroup comparison with animals treated with CPAP or IPPV at 20 minutes after CPR.
Hemodynamic and Respiratory Variables
Data are presented in Table 3 and Figure 2 . No significant intergroup difference could be detected at any point in time.
Survival and Measurements Taken After Defibrillation
We attempted to resuscitate the animals after reaching the end point of the experiment. These data are presented in Tables 1  to 3 under the ROSC headings and also in Figures 1 and 2 . Eight of 8 animals ventilated with CPAP PSV could be resus- 
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citated, whereas 6 of 8 animals treated with CPAP and 3 of 8 treated with IPPV could be successfully defibrillated. The difference between CPAP PSV and IPPV was significant (Pϭ0.025).
Discussion
In the present study, we examined pulmonary gas exchange using 3 modes of ventilation: CPAP PSV , genuine CPAP, and IPPV during CPR. CPAP PSV triggered by the chest compressions resulted in the lowest AaDO 2 and thus in the highest PaO 2 . This was based on significantly more pulmonary blood flow to lung areas with a normal V A/Q ratio. A remarkable finding was that V O 2 during CPR with CPAP PSV was not significantly different from the pre-arrest value.
Effect on Ventilation and Carbon Dioxide Elimination
In CPR, IPPV is applied asynchronously to chest compressions, whereas CPAP simply provides a permanent status of inspiration that is interrupted by expirations caused by chest compression. The CPAP PSV concept for CPR improves on CPAP by adding actively triggered inspiration. In contrast to the other modes examined, in CPAP PSV both inspiration and expiration are active. Transcending the CPAP concept, in CPAP PSV , thoracic recoil and pressure support provided 2 independent factors that assisted inspiration during the period of decompression.
The breathing pattern that developed during CPAP PSV appeared to be unusually fast paced. Respiratory rate at the second time point during CPAP PSV was 73Ϯ16 breaths/min; thus, Ͼ80% of the chest compressions were accompanied by a respiratory cycle. Mean VT at this time point was 96Ϯ19 mL total in a respiratory minute volume of 7.6Ϯ1.9 L/min. Small VT ventilation at high respiratory rates results in considerable dead space ventilation, which potentially impairs carbon dioxide elimination because alveolar ventilation is consequently reduced. PaCO 2 , however, was 50Ϯ7 mm Hg during CPAP PSV , still within an acceptable range. Ventilation and chest compressions are not synchronized when IPPV is used during CPR, which must result in interference of chest compression with inspiration. Accordingly, both CPAP and CPAP PSV resulted in significantly lower peak airway pressures (PϽ0.001) than IPPV. Although the hemodynamic consequences of this cannot be drawn conclusively from our data, the airway pressures observed during IPPV (39Ϯ6 mm Hg) increase the risk of barotrauma. 14,15
Effect on Arterial Blood Gases
Despite significantly higher PaO 2 and a significantly lower AaDO 2 in animals treated with CPAP PSV , hypercarbia (PaCO 2 50Ϯ7 mm Hg) was observed in the CPAP PSV and CPAP groups ( Table 2) . Increased PaCO 2 caused by an increase in hydrogen ions shifts the oxygen dissociation curve to the right, thus facilitating the unloading of oxygen to the tissues (Bohr effect). In this study, CPAP PSV provided the highest PaO 2 with moderate arterial hypercarbia (PaCO 2 50Ϯ7 mm Hg). Thus, although the hemoglobin was highly saturated with oxygen (95Ϯ3%), it had a reduced affinity for oxygen. Together with a low cardiac output, this in part explains the large arterial-venous oxygen partial pressure difference of Ϸ100 mm Hg found with CPAP PSV . In fact, V O 2 was highest in those subjects treated with CPAP PSV (see below). Also, because the carbon dioxide transport capacity of hemoglobin depends on the amplitude of peripheral deoxygenation, a higher oxygen extraction ratio improves tissue carbon dioxide elimination (Haldane effect).
Effect on Efficiency of Gas Exchange
In this setting of extremely low cardiac output (Figure 2) , it is crucial that most of the pulmonary blood flow be directed to lung units with a normal V A/Q ratio to achieve the highest possible oxygen delivery at a given hemoglobin concentration. CPAP PSV resulted in a significantly higher percentage of blood flow to these units than did CPAP (PϽ0.01) or IPPV (PϽ0.01). When compression and inspiration occur simultaneously, intrathoracic pressure must rise, contributing to the rightward shift of the distribution of ventilation (mean of V ). Blood flow to these lung units with a higher V A/Q ratios was also increased with IPPV, however, resulting in a rightshifted V A/Q matching that prevented further decreases in PaO 2 . Conversely, such shifts produce less blood flow to lung units with lower V A/Q ratios, including those units with a normal ratio. Therefore, and because of the high AaDO 2 in the IPPV group, the decrease in oxygen partial pressures from air to pulmonary end-capillary blood amounted to Ϸ138 mm Hg, a large value compared with Ϸ50 mm Hg in a healthy, spontaneously breathing subject at sea level.
It should be noted that all animals examined had excellent lung function at baseline; nevertheless, there were significant differences between groups at the measurement after 20 minutes of CPR. The question arises as to whether the magnitude of differences between the groups examined can be extrapolated to subjects with impaired gas exchange. For instance, ventilation-perfusion inequality in chronic asthma, as expressed as the second moment of the distribution of perfusion (log SDQ), was found to be 0.74 (mean of 26 subjects). 16 Log SDQ in the animals in this experiment was only 0.48, consistent with previously published data collected in awake pigs 13 and normal humans 10 indicating healthy lungs. It is likely that differences in gas exchange and resulting PaO 2 between the modes examined would be more pronounced in subjects with an already existing gas exchange disorder.
Effect on V O 2
V O 2 was by far highest in the CPAP PSV group (Figure 2) , an unanticipated finding. In animals treated with CPAP PSV , the V O 2 at 20 minutes of CPR was unchanged (Pϭ0.23) compared with baseline. In other words, CPR did not affect V O 2 in the CPAP PSV group. Which factors contributed to the differences in V O 2 ? Arterial oxyhemoglobin saturation and mixed venous oxyhemoglobin saturation during CPAP PSV were higher or lower, respectively, compared with CPAP or IPPV, although not all differences reached significance. With regard to hemodynamics, insignificant differences in systolic, mean, and diastolic pressures may have and in cardiac output will have contributed to the higher V O 2 in the CPAP PSV group. This animal model, however, cannot derive whether blood flow has been redistributed to a normal pattern and whether all organs had a better V O 2 during CPAP PSV .
Resuscitability
Although it was beyond the primary end point of this experiment, defibrillation was attempted after the measurement after 20 minutes of CPR. CPAP PSV resulted in a significantly higher occurrence of ROSC in this animal model (CPAP 
Applicability of CPAP PSV and Critique of the Methods
It should be noted that these results obtained in a porcine model cannot be fully extrapolated to resuscitation in the intensive care unit or in the field. Although CPAP PSV offers a number of advantages, practicability and application in the field may be limited. First, elasticity and elastic recoil of lung and thorax determine the effectiveness of CPAP PSV during CPR. Partly ossified rib cartilages and a consequently stiffer thorax will limit the efficacy of CPAP PSV in this setting. Second, accidental development of a pneumothorax, as may occur during CPR, 17, 18 will clearly limit the applicability of CPAP PSV in this setting. Third, optimal CPAP and CPAP PSV levels that manifest in a higher survival rate remain to be determined.
We conclude that CPAP PSV may be used as a simple and effective decompression-triggered mode of ventilation during CPR that provides improvements in pulmonary gas exchange and a pre-arrest range of V O 2 .
